bluebird bio, Inc. Selling, General and Administrative Expense
bluebird bio, Inc. reported Selling, General and Administrative Expense of $30.26 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-05-14
- bluebird bio, Inc. selling, general and administrative expense for the quarter ending 2025-03-31 was $30.26M, a 34.68% decline year-over-year.
- bluebird bio, Inc. selling, general and administrative expense for the quarter ending 2024-12-31 was $31.39M, a 32.93% decline year-over-year.
- bluebird bio, Inc. selling, general and administrative expense for the quarter ending 2024-09-30 was $39.77M, a 2.47% decline year-over-year.
- bluebird bio, Inc. selling, general and administrative expense for the quarter ending 2024-06-30 was $50.38M, a 24.52% increase year-over-year.
- bluebird bio, Inc. selling, general and administrative expense for fiscal 2024 was $167.87M, a 1.43% increase from fiscal 2023.
- bluebird bio, Inc. selling, general and administrative expense for fiscal 2023 was $165.51M, a 17.95% increase from fiscal 2022.
- bluebird bio, Inc. selling, general and administrative expense for fiscal 2022 was $140.33M, a 33.17% decline from fiscal 2021.
- bluebird bio, Inc. selling, general and administrative expense for fiscal 2021 was $209.97M, a 12.49% decline from fiscal 2020.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $30.26M 10-Q · filed 2025-05-14 | $61.66M derived: sum of 2 quarters · filed 2025-05-14 | $101.42M derived: sum of 3 quarters · filed 2025-05-14 | $151.81M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-12-31 | $31.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $71.16M derived: sum of 2 quarters · filed 2025-03-27 | $121.55M derived: sum of 3 quarters · filed 2025-03-27 | $167.87M 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | $39.77M 10-Q · filed 2024-11-14 | $90.15M derived: sum of 2 quarters · filed 2024-11-14 | $136.48M 10-Q · filed 2024-11-14 | $183.29M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-06-30 | $50.38M 10-Q · filed 2024-09-27 | $96.71M 10-Q · filed 2024-09-27 | $143.52M derived: sum of 3 quarters · filed 2025-05-14 | $184.29M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-03-31 | $46.33M 10-Q · filed 2025-05-14 | $93.14M derived: sum of 2 quarters · filed 2025-05-14 | $133.91M derived: sum of 3 quarters · filed 2025-05-14 | $174.37M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $46.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $87.58M derived: sum of 2 quarters · filed 2025-03-27 | $128.04M derived: sum of 3 quarters · filed 2025-03-27 | $165.51M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $40.77M 10-Q · filed 2024-11-14 | $40.70M 10-Q · filed 2023-11-07 | $81.23M derived: sum of 2 quarters · filed 2024-11-14 | $118.70M 10-Q · filed 2024-11-14 | $118.41M 10-Q · filed 2023-11-07 | $152.82M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $40.46M 10-Q · filed 2024-09-27 | $40.35M 10-Q · filed 2023-08-08 | $77.93M 10-Q · filed 2024-09-27 | $77.70M 10-Q · filed 2023-08-08 | $112.05M derived: sum of 3 quarters · filed 2024-09-27 | $145.46M derived: sum of 4 quarters · filed 2024-09-27 | ||
| 2023-03-31 | $37.47M 10-Q · filed 2024-09-13 | $37.35M 10-Q · filed 2023-05-09 | $71.59M derived: sum of 2 quarters · filed 2024-09-13 | $104.99M derived: sum of 3 quarters · filed 2024-09-13 | $141.69M derived: sum of 4 quarters · filed 2024-09-13 | |||
| 2022-12-31 | $34.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-13 | $67.53M derived: sum of 2 quarters · filed 2024-09-13 | $104.22M derived: sum of 3 quarters · filed 2024-09-13 | $140.33M 10-K · filed 2024-09-13 | $136.91M 10-K · filed 2023-03-29 | |||
| 2022-09-30 | $33.40M 10-Q · filed 2023-11-07 | $70.10M derived: sum of 2 quarters · filed 2023-11-07 | $106.20M 10-Q · filed 2023-11-07 | $159.41M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $36.69M 10-Q · filed 2023-08-08 | $72.80M 10-Q · filed 2023-08-08 | $126.01M derived: sum of 3 quarters · filed 2023-08-08 | $168.24M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $36.11M 10-Q · filed 2023-05-09 | $89.31M derived: sum of 2 quarters · filed 2023-05-09 | $131.54M derived: sum of 3 quarters · filed 2023-05-09 | $186.53M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $53.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $95.44M derived: sum of 2 quarters · filed 2023-03-29 | $150.42M derived: sum of 3 quarters · filed 2023-03-29 | $209.97M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $42.23M 10-Q · filed 2022-11-07 | $68.28M 10-Q · filed 2021-11-05 | $97.21M derived: sum of 2 quarters · filed 2022-11-07 | $156.76M 10-Q · filed 2022-11-07 | $229.71M 10-Q · filed 2021-11-05 | $190.81M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-06-30 | $54.98M 10-Q · filed 2022-08-04 | $78.58M 10-Q · filed 2021-08-09 | $118.55M 10-Q · filed 2022-08-04 | $165.45M 10-Q · filed 2021-08-09 | $148.58M derived: sum of 3 quarters · filed 2023-03-29 | $216.63M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-03-31 | $63.57M 10-Q · filed 2022-05-09 | $86.87M 10-Q · filed 2021-05-05 | $93.60M derived: sum of 2 quarters · filed 2023-03-29 | $161.64M derived: sum of 3 quarters · filed 2023-03-29 | $230.27M derived: sum of 4 quarters · filed 2023-03-29 | |||
| 2020-12-31 | $30.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $98.07M derived: sum of 2 quarters · filed 2023-03-29 | $166.70M derived: sum of 3 quarters · filed 2023-03-29 | $239.95M 10-K · filed 2023-03-29 | $286.90M 10-K · filed 2021-02-23 | |||
| 2020-09-30 | $68.05M 10-Q · filed 2021-11-05 | $136.67M derived: sum of 2 quarters · filed 2021-11-05 | $209.92M 10-Q · filed 2021-11-05 | $250.61M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-06-30 | $68.63M 10-Q · filed 2021-08-09 | $141.88M 10-Q · filed 2021-08-09 | $182.56M derived: sum of 3 quarters · filed 2022-03-04 | $248.81M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-03-31 | $73.25M 10-Q · filed 2021-05-05 | $113.93M derived: sum of 2 quarters · filed 2022-03-04 | $180.18M derived: sum of 3 quarters · filed 2022-03-04 | $248.81M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2019-12-31 | $40.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $106.93M derived: sum of 2 quarters · filed 2022-03-04 | $175.56M derived: sum of 3 quarters · filed 2022-03-04 | $235.84M 10-K · filed 2022-03-04 | $271.36M 10-K · filed 2020-02-18 | |||
| 2019-09-30 | $66.25M 10-Q · filed 2020-11-04 | $134.88M derived: sum of 2 quarters · filed 2020-11-04 | $195.16M 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | $68.63M 10-Q · filed 2020-08-05 | $128.91M 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | $60.28M 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | $174.13M 10-K · filed 2021-02-23 | |||||||
| 2017-12-31 | $93.55M 10-K · filed 2020-02-18 |